De toegevoegde waarde van magnetic resonance imaging in detectie van prostaatkanker.
- Conditions
- prostate cancer detection, diagnose prostaatkanker
- Registration Number
- NL-OMON21521
- Lead Sponsor
- Radboud University Medical CentreDepartment of Radiology
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
1. PSA¡Ý4.0 ng/ml;
2. One or more previous negative TRUS guided prostate biopsies;
Exclusion Criteria
1. Patients with known contradictions to MRI;
2. Patients with known contra-indications to Gadolinium based contrast agents;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection rates of MRGB compared to a second or later TRUSGB examination. Timepoint:8 weeks.
- Secondary Outcome Measures
Name Time Method 1. Detection rate of MRUSFGB. Timepoint: 8 weeks;<br /><br>2. Percentage of patients upgraded(with an increase of one point in Gleason score on MRGB and MRUSFGB compared tot TRUSGB) by MRGB and MRUSFGB Gleason score respectively compared to TRUSGB Gleason score. Timepoint: 8 weeks.<br>